Order Article Reprints

Hauschulz M, Villwock S, Kosinski J, Steib F, Heij LR, Bednarsch J, Knüchel-Clarke R, Dahl E. Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers. 2023; 15(3):683. https://doi.org/10.3390/cancers15030683

Hauschulz, Maximilian, Sophia Villwock, Jennifer Kosinski, Florian Steib, Lara Rosaline Heij, Jan Bednarsch, Ruth Knüchel-Clarke, and Edgar Dahl. 2023. "Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer" Cancers 15, no. 3: 683. https://doi.org/10.3390/cancers15030683

Hauschulz, M., Villwock, S., Kosinski, J., Steib, F., Heij, L. R., Bednarsch, J., Knüchel-Clarke, R., & Dahl, E. (2023). Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer. Cancers, 15(3), 683. https://doi.org/10.3390/cancers15030683